...
机译:HSP70 / HSF1轴,通过PI3K / AKT途径调节,是慢性淋巴细胞白血病中的可药剂靶标
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Woman's and Child's HealthUniversity of PaduaPadua Italy;
Department of Woman's and Child's HealthUniversity of PaduaPadua Italy;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Woman's and Child's HealthUniversity of PaduaPadua Italy;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
Department of Medicine Hematology and Clinical Immunology BranchPadua University School of;
HSP70; HSF1; chronic lymphocytic leukemia; inhibition; signal transduction;
机译:HSP70 / HSF1轴,通过PI3K / AKT途径调节,是慢性淋巴细胞白血病中的可药剂靶标
机译:解剖未突变疾病患者的慢性淋巴细胞白血病微环境信号:microRNA-22调节增殖性白血病细胞中的磷酸酶和张力蛋白同源物/ AKT / FOXO1途径
机译:肿瘤抑制剂MiR-139-5P靶向TSPAN3并通过PI3K / AKT途径调节急性髓细胞白血病的进展
机译:基于质谱的磷蛋白蛋白酶鉴定慢性淋巴细胞白血病(CLL)磷酸化信号通路
机译:多靶点受体酪氨酸激酶抑制剂利尼法尼(ABT-869)通过磷酸肌醇3激酶(PI3K)/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
机译:三氧化二砷和pI3K / aKT通路在慢性淋巴细胞白血病
机译:HSP70 / HSF1轴通过PI3K / AKT途径调节,是慢性淋巴细胞白血病中的可耐药靶标